CSL Behring Medical Expert Portal is a global web portal designed for healthcare professionals (HCPs) outside the US who are interested in serious and life-threatening conditions. Register and login to access the information on this webpage and to receive updates when new content becomes available for your country. The medical and scientific information provided on this website is for informational purposes only and should not replace professional advice from a healthcare provider in your area. Product labels may vary from country to country. Please ensure to follow the applicable label for your country.

Disclaimer: Due to compliance regulations, not all content of this webpage is intended for UK healthcare practitioners. If you would like to access UK specific materials on this site, please reach out to your local CSL Behring medical representative (medinfo@cslbehring.com) for assistance.

Disclaimer

CSL EXPERT HIVE

Symposia replays

EAHAD 2025: First EU real-world gene therapy experiences in haemophilia B

Pathology:

Haemophilia B

EAHAD 2025: First EU real-world gene therapy experiences in haemophilia B

Duration: 58m39s

Watch the full symposium video recording of the CSL Behring EAHAD satellite symposium held on February 2, 2021.

The symposium was chaired by Michiel Coppens, and features three pre-recorded presentations from Catherine Lambert, Johannes Oldenburg and Will Lester that highlight challenging obstacles to patient care in haemophilia A and B and von Willebrand disease. Each presentation is followed by a live Q&A session.

The content in this video recording is from a CSL Behring-sponsored promotional symposium and is intended for Health Care Professionals (HCPs) only.

Prescribing information may vary depending on local approval in each country; before prescribing the products in this presentation, please refer to the local prescribing information or Summary of Product Characteristics (SmPC).